Univar announces success of API distribution partnership with India’s Gharda Chemicals
Univar announced that its partnership with Indian supplier, Gharda Chemical Limited, has been a great success. After guiding Gharda through the process of gaining EU regulatory approval, Univar is now commercially distributing their active pharmaceutical ingredients (APIs) across Europe.
Univar is distributing a range of Synthetic Pyrethroids that include Permethrin, Cypermethrin and Deltamethrin. The products are used predominantly in the animal health sector but have other applications including domestic insect control and in public health programmes. They are also recommended for use in head lice shampoos and as biocides.
The partnership with Gharda came about after a large European pharmaceutical company approached Univar to identify a reliable source of Synthetic Pyrethroids for them. Univar found Gharda who had the products in their range as well as a strong track record of reliable delivery.
Univar drew on its experience in the European API market to ensure both supplier and customer needs were fulfilled and provided the necessary guidance and support to ensure regulatory and quality compliance as well as arranging for their pharmaceutical customer to audit and qualify the production site.
Organizations
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents
Diabetes advance: Researchers find gene that causes resistance to insulin - Discovery is first gene known to affect how insulin works, not how it is produced

ZEISS Ventures invests in life science start-up InSphero to drive 3D cell culture research - Strategic investment is closely linked to ZEISS Research Microscopy Solutions and its capabilities in automated, high-resolution imaging and 3D image analysis

Culture Biosciences Raises $80M Series B to Tackle Demand for Large-Scale Biomanufacturing - Culture is closing the gap in manufacturing capacity with its large-scale cloud bioreactors
Mechanical heart valve prosthesis superior to biological
